15 million of raw materials for the COVID-19 vaccine arrived in Indonesia on Tuesday afternoon from the Chinese drug-maker, Sinovac - Photo by President Office

JAKARTA (TheInsiderStories) – 15 million of raw materials for the COVID-19 vaccine from the Chinese drug-maker, Sinovac arrived in Indonesia on Tuesday afternoon, said head of task force for the health crisis management, Doni Monardo. The bulk will be further processed into ready-to-use vaccines by the state firm, PT Bio Farma.

The arrival of 15 million doses of raw material is the third arrival after 1.2 million and 1.8 million ready-to-use vaccines have arrived in Indonesia in the previous two arrivals. To note, the Coronavac has received an emergency use permit from the Food and Drug Supervisory Agency and also had obtained a halal fatwa from the Indonesian Ulema Council.

Before being given to the public, the vaccine has gone through clinical and other scientific trials and its safety. Indonesia immediately prepares to begin mass-deploying vaccinations. A total of approximately 181.5 million Indonesians, who comply with the health requirements and criteria, will receive the vaccine for free.

“The President always reminds us that this vaccine should not make us slack. This vaccine must be balanced with adherence to health protocols, namely wearing masks, maintaining distance, prohibiting crowding, and washing hands frequently with soap and running water,” said Monardo in an official statement today.

Minister of health, Budi Gunadi Sadikin, has said Indonesia needs 426 million dosses of COVID-19 vaccines to secure “herd immunity” in Indonesia. Beside Sinovac, he continued, the government also has secured around 181 million doses from United States (US)’ drug-maker Pfizer and British’ AstraZeneca.

According to the minister, Budi Gunadi Sadikin, in a virtual conference, taking into account that one person needs two doses of vaccine and 15 percent as a reserve in accordance with the provisions of the World Health Organization (WHO), the total vaccine needed is around 426 million doses. To reached the targets, he said, the government has ensured to meet the number of vaccines.

Currently, he said, the government has signed a contract for 125 million doses of vaccine from Sinovac with an additional option to 100 million doses of vaccines and 130 million total doses of vaccine from US’ Novavax. In addition, the government will also sign a contract with AstraZeneca to obtain up to 100 million doses of vaccine and another 100 million other doses which will also be imported from BioNTech-Pfizer.

Sadikin stated, a 50-million-dose deal with AstraZeneca would be finalized before end of 2020, and the same size with Pfizer in the first week of January. In total, said the minister, Indonesia will receive 660 million doses of vaccine including from CEVI and GAVI-COVAX, a public – private global health partnership.

While, the CEO of Bio Farma, Honesti Basyir, said Indonesian government need funds around Rp68 trillion (US$4.82 billion) to produces vaccines in 2021. The former CEO of PT Kimia Farma Tbk (IDX: KAEF), revealed, the assumption based on the vaccine price of Rp200,000 a dose. 

US$1: Rp14,100

Written by Editorial Staff, Email: theinsiderstories@gmail.com